0001779372 false 0001779372 2023-07-07 2023-07-07 0001779372 us-gaap:CommonStockMember 2023-07-07 2023-07-07 0001779372 us-gaap:WarrantMember 2023-07-07 2023-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 7, 2023

 

HEARTBEAM, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware   001-41060   47-4881450

(State or other jurisdiction

of incorporation)

  

(Commission File Number)

  

(IRS Employer

Identification No.)

 

2118 Walsh Avenue, Suite 210

Santa Clara, CA 95050

(Address of principal executive offices, including zip code)

 

(408) 899-4443

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   BEAT   NASDAQ
Warrant   BEATW   NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On July 7, 2023, HeartBeam, Inc. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”) virtually, via live webcast.

 

As of the close of business on May 10, 2023, the record date for the Annual Meeting (the “Record Date”), 25,901,240 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”) were outstanding and entitled to vote. At the Annual Meeting, a total of 17,719,273 votes, comprised of shares of the Company’s Common Stock, equivalent to approximately 68.41% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The matters that were voted upon at the Annual Meeting, and the number of votes cast for or against/withheld, as well as the number of abstentions and broker non-votes, as to such matters, where applicable, are set forth below.

 

1.The five nominees for director were elected to serve a one-year term as follows:

 

Director  Votes For   Votes
Against		   Abstain   Broker
Non-Vote		 
Richard Ferrari   14,018,463    176,653    63,762    3,460,395 
Branislav Vajdic, PhD   14,178,136    26,781    53,961    3,460,395 
George A. de Urioste   13,921,915    161,275    175,688    3,460,395 
Marga Ortigas-Wedekind   14,180,333    24,414    54,131    3,460,395 
Willem Elfrink   14,034,713    160,535    63,630    3,460,395 

 

2. The proposal to ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was approved as follows:

 

Votes For   Votes Against   Broker Non-Votes   Votes Abstained 
 17,691,638    8,471    0    19,164 

 

3. The proposal to amend the 2022 Equity Incentive Plan to increase the number of authorized shares from 1,900,000 shares to 5,900,000 shares:

 

Votes For   Votes Against   Broker Non-Votes   Votes Abstained 
 13,469,751    788,072    3,460,395    1,055 

 

(d) Exhibits.

 

Exhibit
Number

   Description
10.1   First Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

  

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  HeartBeam, Inc.
     
Date: July 11, 2023 By: /s/ Richard Brounstein
  Name: Richard Brounstein
  Title: Chief Financial Officer

 

 

2

 

Exhibit 10.1

 

FIRST AMENDMENT TO THE

HEARTBEAM, INC.

2022 EQUITY INCENTIVE PLAN

 

Effective as of June 15, 2022, HeartBeam, Inc., a Delaware corporation (the “Company”), established, and the shareholders approved, the Company’s 2022 Equity Incentive Plan (the “2022 Equity Plan”). By adoption of this instrument, the Company now desires to amend (the “First Amendment”) the 2022 Equity Plan to increase the maximum number of shares available for issuance under the Plan by 4,000,000 from 1,900,000 to 5,900,000 shares.

 

1.This Amendment shall be effective as of the date it is approved by the Company’s shareholders at the Company’s 2023 Annual Meeting and shall be void in the absence of such approval.

 

2.Section 3(a)(i) of the 2022 Equity Plan (Shares Subject to the Plan) is hereby amended and restated in its entirety to read as follows:

 

a.“Allocation of Shares to Plan. The maximum aggregate number of Shares that may be issued under the Plan is:

 

(i) 5,900,000 Shares, plus up to 1,178,194 shares of Common Stock that may become available for issuance as a result of recycling of awards under the 2015 Equity Incentive Plan”

 

3.This First Amendment shall only amend the provisions of the 2022 Equity Plan referred to above, and those provisions not amended hereby shall be considered in full force and effect, unless the context indicates otherwise.

 

IN WITNESS WHEREOF, the Company has caused this First Amendment to be signed by Branislav Vajdic, a duly authorized officer of the Company, on July 7, 2023.

 

Dated: July 7, 2023 /s/ Branislav Vajdic
  Branislav Vajdic
  Chief Executive Officer

 

v3.23.2
Cover
Jul. 07, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 07, 2023
Entity File Number 001-41060
Entity Registrant Name HEARTBEAM, INC.
Entity Central Index Key 0001779372
Entity Tax Identification Number 47-4881450
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2118 Walsh Avenue
Entity Address, Address Line Two Suite 210
Entity Address, City or Town Santa Clara
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95050
City Area Code 408
Local Phone Number 899-4443
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
Common Stock [Member]  
Title of 12(b) Security Common Stock
Trading Symbol BEAT
Security Exchange Name NASDAQ
Warrant [Member]  
Title of 12(b) Security Warrant
Trading Symbol BEATW
Security Exchange Name NASDAQ
HeartBeam (NASDAQ:BEAT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos HeartBeam.
HeartBeam (NASDAQ:BEAT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos HeartBeam.